These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 12520118

  • 1. Preparation of dry powder inhalation by surface treatment of lactose carrier particles.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Leuenberger H.
    Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):1-5. PubMed ID: 12520118
    [Abstract] [Full Text] [Related]

  • 2. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed.
    Iida K, Todo H, Okamoto H, Danjo K, Leuenberger H.
    Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):431-4. PubMed ID: 15802846
    [Abstract] [Full Text] [Related]

  • 3. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):350-3. PubMed ID: 14993760
    [Abstract] [Full Text] [Related]

  • 4. Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenbergerb H.
    Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1455-7. PubMed ID: 14646332
    [Abstract] [Full Text] [Related]

  • 5. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):938-42. PubMed ID: 15304985
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Leuenberger H.
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1326-30. PubMed ID: 11605663
    [Abstract] [Full Text] [Related]

  • 7. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):444-6. PubMed ID: 15056961
    [Abstract] [Full Text] [Related]

  • 8. [Effect of separation characteristics between salbutamol sulfate (SS) particles and model carrier excipients on dry powder for inhalation].
    Iida K, Leuenberger H, Fueg LM, Müller-Walz R, Danjo K.
    Yakugaku Zasshi; 1999 Oct; 119(10):752-62. PubMed ID: 10518459
    [Abstract] [Full Text] [Related]

  • 9. [Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS)].
    Iida K, Leuenberger H, Fueg LM, Müller-Walz R, Okamoto H, Danjo K.
    Yakugaku Zasshi; 2000 Jan; 120(1):113-9. PubMed ID: 10655787
    [Abstract] [Full Text] [Related]

  • 10. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW, Lim LT, Heng PW.
    J Pharm Sci; 2003 May; 92(5):975-84. PubMed ID: 12712417
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
    Lee HJ, Lee HG, Kwon YB, Kim JY, Rhee YS, Chon J, Park ES, Kim DW, Park CW.
    Eur J Pharm Sci; 2018 May 30; 117():279-289. PubMed ID: 29510172
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN, Bierend H, Robins E, Steckel H, Flament MP.
    Int J Pharm; 2012 Jan 17; 422(1-2):75-82. PubMed ID: 22036653
    [Abstract] [Full Text] [Related]

  • 16. A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    Shalash AO, Elsayed MMA.
    AAPS PharmSciTech; 2017 Nov 17; 18(8):2862-2870. PubMed ID: 28421352
    [Abstract] [Full Text] [Related]

  • 17. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 17; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 18. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ, Jain RR, Soni PS, Abdul S, Darshana H, Gaikwad RV, Menon MD.
    J Aerosol Med Pulm Drug Deliv; 2015 Aug 28; 28(4):254-67. PubMed ID: 25517187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.